Clinical Trial: Intravenous Dexamethasone for Ropivacaine Axillary Block
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Intravenous Dexamethasone Versus Placebo for Ultrasound Guided Axillary Brachial Plexus Block With Ropivacaine: Randomised, Controlled, Clinical Trial
Brief Summary: Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block
Detailed Summary:
Sponsor: Centre Hospitalier Universitaire de Besancon
Current Primary Outcome: Analgesia duration after axillary brachial plexus block [ Time Frame: time to first pain at surgical site, an average of 24 hours ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Motor block duration after axillary brachial plexus block Safety [ Time Frame: up to block recovery, an average of 24 hours ]
- Sensory block duration after axillary brachial plexus block [ Time Frame: up to block recovery, an average of 24 hours ]
- incidence of adverse event [ Time Frame: 6 month ]
Original Secondary Outcome: Same as current
Information By: Centre Hospitalier Universitaire de Besancon
Dates:
Date Received: July 22, 2016
Date Started: December 2016
Date Completion: October 2018
Last Updated: December 14, 2016
Last Verified: December 2016
